Syncom Formulations incorporates wholly owned subsidiary in UAE

05 Mar 2012 Evaluate

Syncom Formulations India, in order to expand its geographical presence, has incorporated a wholly owned subsidiary company, in the name of 'TRADE ZONE FZE' in the United Arab Emirates to further develop the existing export activities and facilitate the Company’s new export opportunities.

Further the company has also obtained trading license for para pharmaceutical products, medical, surgical articles and requisites trading and medical, surgical equipments, and instruments from the Government of Ras Al Khimah, UAE.

The company is engaged in the business of pharmaceutical formulations. It manufactures range of products in various dosage forms and markets them in various countries. In addition to pharmaceutical formulations in the form of tablets, capsules, liquids and dry powders, the company also manufactures Injectibles, inhalers and ear/eye drops. In 1994, the company undertook an expansion programme of setting up a new plant for manufacturing pharmaceutical formulations at Pithampur, Madhya Pradesh.

Syncom Formulations Share Price

12.97 0.02 (0.15%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×